It is available as a subcutaneous injection and should be administered in the abdomen, thigh, or upper arm
So, what are your long-term weight loss prospects on Mounjaro
Es importante aclarar que los productos GLP-1 actualmente disponibles en Estados Unidos incluyen formulaciones inyectables (semaglutida, dulaglutida, liraglutida, exenatida) y una formulacin oral (semaglutida, Rybelsus)
Why patients escalate to higher doses Patients and doctors consider escalating the dose primarily for two medical reasons: to improve glycemic control for type 2 diabetes and to overcome weight loss plateaus
If something isnt working or if a concern arises the protocol changes
Tirzepatide activates both GLP-1 and GIP receptors, which slow gastric emptying to promote fullnessa mechanism that can lead to constipation in approximately 20-30% of patients during the first 4-8 weeks of therapy